Infanrix IPV inj. susp. i.m. pre-filled syr.

Land: Belgia

Språk: engelsk

Kilde: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktiv ingrediens:

Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/0,5 ml; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/0,5 ml; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Bordetella Pertussis Pertactin 8 µg/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/0,5 ml

Tilgjengelig fra:

GlaxoSmithKline Biologicals SA-NV

ATC-kode:

J07CA02

INN (International Name):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Legemiddelform:

Suspension for injection

Sammensetning:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Administreringsrute:

Intramuscular use

Terapeutisk område:

Diphtheria-Pertussis-Poliomyelitis-Tetanus

Produkt oppsummering:

CTI code: 212152-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 212152-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - FMD code: 05400571000808 - CNK code: 1552215 - Delivery mode: Medical prescription

Autorisasjon status:

Commercialised: Yes

Autorisasjon dato:

2000-03-13